CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (2,230,504)	$ (1,507,534)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	63,751	11,899
Deferred income tax	3,065	0
Stock-based compensation expense	83,848	119,139
Amortization of financing costs	29,914	28,308
Amortization of debt discount	115,609	79,381
Change in fair value of warrant and conversion feature liability	213,718	30,005
Changes in assets and liabilities:
Accounts receivable	108,827	4,273
Other receivables	(120,151)	0
Due from affiliates	(14,748)	(20,482)
Prepaid expenses and advances	20,698	(5,267)
Deferred financing costs	513,347	0
Other assets	6,570	2,955
Accounts payable and accrued liabilities	790,613	(4,797)
Medical liabilities	(112,904)	163,677
Net cash used in operating activities	(528,347)	(1,098,443)
CASH FLOWS FROM INVESTING ACTIVITIES:
Acquisition, net of cash and cash equivalents acquired	0	216,361
Property and equipment acquired	0	(11,973)
Net cash provided by investing activities	0	204,388
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on term note payable	0	(175,000)
Distributions to non-controlling interest shareholder	(595,418)	0
Net cash used in financing activities	(595,418)	(175,000)
NET DECREASE IN CASH & CASH EQUIVALENTS	(1,123,765)	(1,069,055)
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	5,014,242	6,831,478
CASH & CASH EQUIVALENTS, END OF PERIOD	3,890,477	5,762,423
SUPPLEMENTARY DISCLOSURES OF CASH FLOW INFORMATION:
Interest paid	100,959	150,486
Income taxes paid	32,197	11,129
Non-Cash Financing Activities:
Holdback liability	$ 0	$ 136,822